[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@tom_the_bomb__ Avatar @tom_the_bomb__ ⛏🅾️Ⓜ️💣

⛏🅾️Ⓜ️💣 posts on X about $azn, letsgo, ggp, $991m the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% finance XXX% currencies XXX% cryptocurrencies XXX%

Social topic influence $azn #10, letsgo 0.7%, ggp 0.7%, $991m 0.7%, $pfe 0.7%, unlock 0.7%, $43b 0.7%, pfe 0.7%, top1 0.7%, $dsnky XXX%

Top accounts mentioned or mentioned by @avacta @asininitybeyond @seandentbsc @bobdibble8 @rah00084 @neutroniclse @andrewdigby3 @tragedycalls @towlie1981 @jeskirrane @esspekay @jstonker @novartis @elilillyandco @tren116 @mike182035 @blueberrymgmnt @snscreenwriter @elkhunter78 @111ben111

Top assets mentioned AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY) Novartis AG (NVS) ROGin AI (ROG)

Top Social Posts #

Top posts by engagements in the last XX hours

"Just added more #AVCT & #MKA to my SIPP. Two companies that I believe will have a great Q4 2025 & more broadly throughout 2026. I added to #GGP last week too. #LetsGo DYOR"
X Link @tom_the_bomb__ 2025-10-09T07:11Z 3302 followers, 5565 engagements

"Boehringer Ingelheim advances ADC portfolio with an Exatecan-based ADC (AMB304) from AimedBio worth up to $991M. AMB304 is a preclinical asset. AimedBio have one asset in Phase X. #AVCT"
X Link @tom_the_bomb__ 2025-10-15T16:48Z 3307 followers, 3753 engagements

"I wonder what BP is saying about #AVCTs preCISION platform Pfizer: Buy once unlock Seagens entire ADC portfolio & finally dose TOP1 payloads without hitting toxicity walls. Turns a $43B Seagen buy into a platform that actually reaches its potential. 1/4 #AVCT $PFE"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3304 followers, 3150 engagements

"AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 1795 engagements

""FAP-Dox and FAP-EXd are only the tip of the preCISION iceberg" Under the surface: "preCISION molecules in stages of preclinical testing and prep work for the clinic. Multiple therapeutic classes (n10)" Likely 11-15+ molecules across multiple therapeutic classes. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T11:36Z 3305 followers, 2510 engagements

"@SeanDentBsc 6207 targets multi drug resistance + tumour heterogeneity. Im thinking something like exatecan + a second payload aimed at blocking DNA damage repair (a PARP inhibitor or a similar DNA repair pathway blocker). 6103 + 6207 is a PERFECT fit for AstraZeneca. #AVCT"
X Link @tom_the_bomb__ 2025-10-18T12:44Z 3306 followers, 2807 engagements

"@asininitybeyond @Towlie1981 @PJ_Crabb AI's view below. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T08:39Z 3304 followers, 1964 engagements

"@TBSfrench @AndrewDigby3 Not a shit week RH and his investors moved the SP north by fading the shadow of no cash Are you implying theres another placing on the way"
X Link @tom_the_bomb__ 2025-10-17T21:22Z 3306 followers, XX engagements

"Merck: Combine tumour-activated chemo with #Keytruda to deliver unprecedented tumour clearance while preserving immune function. A whole new class: chemo-immunotherapy XXX. 4/4 #AVCT $MRK"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3306 followers, 3692 engagements

"@AndrewDigby3 @asininitybeyond The CSO has worked at AstraZeneca"
X Link @tom_the_bomb__ 2025-10-14T14:34Z 3300 followers, XXX engagements

"@paddygall1 @shaun_day_ @GreatlandGold 8500oz per vertical metre"
X Link @tom_the_bomb__ 2021-07-02T09:06Z 3307 followers, XX engagements

"Eli Lilly: Leapfrog the ADC incumbents by pairing preCISION-exatecan with our bispecifics radiopharma & IO assets. Precision chemo without the ADC baggage = faster cleaner cheaper. 3/4 #AVCT $LLY"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 2777 engagements

"@asininitybeyond BIG update/insight from TD (IMO). A ATR or PARP inhibitor sits with the recent comments on an incoming pathway inhibitor deal. Few BP have both of these drug classes apart from AstraZeneca. #AVCT's dual-payload linker would solve AZs biggest limitation = overlapping toxicity"
X Link @tom_the_bomb__ 2025-10-14T14:12Z 3304 followers, 1706 engagements

"@SeanDentBsc @TragedyCalls So which will it be. Partnerships then a buyout makes the most sense (and definitely my preference before 6103 data)"
X Link @tom_the_bomb__ 2025-10-16T11:51Z 3306 followers, XXX engagements

"@JStonker They stuck Novartis at the bottom & Avacta at the top next to AZN. 😄 #AVCT is an "Unmissable event highlight" alongside Roche $ROG and AstraZeneca #AZN $AZN. @avacta has a LOT of industry eyes on their patented preCISION tech"
X Link @tom_the_bomb__ 2025-09-02T14:08Z 3301 followers, XXX engagements

"@Jenkoool Huge amounts of money around for preclinical assets. Which is why I keep leaning towards a buyout sooner rather than later. Ample opportunity to sign multiple deals"
X Link @tom_the_bomb__ 2025-10-15T18:38Z 3305 followers, XXX engagements